Stock comparison
ResMed
Tactile Systems Technology
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
RMD
ResMed
Market cap
$30.18B
Sector
Healthcare
TCMD
Tactile Systems Technology
Market cap
$561.65M
Sector
Healthcare
Overall winner
ResMed RMD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | RMD | TCMD | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 54D | RMD |
| Benjamin Graham | 75B | 55D | RMD |
| Philip Fisher | 75B | 48D | RMD |
| Peter Lynch | 58C | 38D | RMD |
| Joel Greenblatt | 47D | 30F | RMD |
| Charlie Munger | 69B | 41D | RMD |
| Terry Smith | 73B | 47D | RMD |
Side-by-side metrics
| Metric | RMD | TCMD |
|---|---|---|
| Market cap | $30.18B | $561.65M |
| P/E (TTM) | 19.6x | 26.6x |
| EV/EBIT | 17.1x | 16.4x |
| ROIC (TTM) | 19.63% | 7.93% |
| Gross margin | 61.69% | 75.68% |
| Net margin | 27.44% | 5.91% |
| Revenue CAGR 5y | 12.64% | 12.18% |
| EPS CAGR 5y | 30.73% | - |
| Debt / Equity | 0.1x | 0.1x |
| Dividend yield | 1.14% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
RMD leads on
- Dividend yield1.14%vs 0.0%+100%
- Market cap$30.18Bvs $561.65M+98%
- Net margin27.44%vs 5.91%+78%
- ROIC (TTM)19.63%vs 7.93%+60%
TCMD leads on
- Debt / Equity0.1xvs 0.1x+46%
- Gross margin75.68%vs 61.69%+18%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.